Jung-a Eom
Chuncheon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
A scheme to tackle the dilemma from hepatoma cells under doxorubicin-resistant surroundings: a brightness or a silhouette.
Journal: Artificial cells, nanomedicine, and biotechnology
Published: July 22, 2026
The unmasking of two-faced portrait in sorafenib-resistant surroundings via systems pharmacology concept: a brightness or a silhouette.
Journal: Artificial cells, nanomedicine, and biotechnology
Published: April 19, 2026
Clinical-data-driven pharmacological framework in liver disease: From liver cirrhosis to hepatocellular carcinoma.
Journal: British journal of pharmacology
Published: September 23, 2025
A roadmap to unveil the mechanism(s) of natural indole-derived molecules against NAFLD-derived HCC via systems pharmacology.
Journal: Translational oncology
Published: May 02, 2025
The assembled decoders to prepare for "bioactive X″ against progressive deterioration of liver disease: From NAFLD to HCC.
Journal: European journal of medicinal chemistry
Published: August 20, 2024
A consortium of Hordeum vulgare and gut microbiota against non-alcoholic fatty liver disease via data-driven analysis.
Journal: Artificial cells, nanomedicine, and biotechnology
Published: April 30, 2024
The epitome of tailor-made short positively charged peptides against HCC via integrated pharmacology.
Journal: Journal of translational medicine
Published: March 07, 2024
A strategy to pioneer key agent(s) in Cephalotaxus alkaloids against pan-cancer via filtering methodology based on integrated pharmacology.
Journal: Journal of translational medicine
Published: March 01, 2024
The seamless integration of dietary plant-derived natural flavonoids and gut microbiota may ameliorate non-alcoholic fatty liver disease: a network pharmacology analysis.
Journal: Artificial cells, nanomedicine, and biotechnology
Published: May 02, 2023
New insight into gut microbiota-derived metabolites to enhance liver regeneration via network pharmacology study.
Journal: Artificial cells, nanomedicine, and biotechnology
Published: December 23, 2022
Elucidation of Prebiotics, Probiotics, Postbiotics, and Target from Gut Microbiota to Alleviate Obesity via Network Pharmacology Study.
Journal: Cells
Published: August 05, 2022
Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role.
Journal: Biomedicines
Published: January 28, 2022
Showing 1-12 of 12
Last Updated: 09/26/2026